Global Point of Care (PoC) Lipid Test Market 360-Degree Research with Current and Future Trends 2022 to 2030

Global Point of Care (PoC) Lipid Test Market 360-Degree Research with Current and Future Trends 2022 to 2030

Global Point of Care (PoC) Lipid Test Market to Witness 4.34% Growth during 2022 – 2030

PUNE, MAHARASHTRA, INDIA, March 30, 2022 / — Global Point of Care (PoC) Lipid Test Market is a latest research study released by Absolute Markets Insights evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides crucial statistics on the market status of the leading Point of Care (PoC) Lipid Test market players and offers information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Point of Care (PoC) Lipid Test Market. The report uses effective graphical presentation techniques, such as graphs, charts, tables as well as pictures for better understanding. The global point of care (PoC) lipid test market was valued at US$ 260.48 Mn in 2021 and is estimated to grow at a CAGR of 4.34% over the forecast period (2022 – 2030).

Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis):

The growing prevalence of target diseases such as cardiovascular disease, diabetes, and dyslipidemia, as well as the changing nature of the medical sector, is driving the global point of care (PoC) lipid test market. Moreover, growing geriatric population across developed and developing economies is also contributing towards the market growth. Points of care (PoC) tests are medical tests that aid in the diagnosis of a problem in the human body at a specific point. PoC testing have several advantages, including the elimination of sample transportation to the central laboratory, a simple analytic process, a small sample requirement (e.g., only a drop of blood), and very quick availability of results (1–2 minutes). Increased investments by major companies to develop technologically advanced point of care (PoC) lipid test devices are expected to drive the growth of global point of care (PoC) lipid test market during the forecast period. For example, Abbott’s Cholestech Ldx Analyzer is designed to deliver accurate, actionable, and easily accessible results that have become an industry standard in point-of-care lipid profile, cholesterol, and glucose testing. It provides data for immediate risk assessment and therapeutic monitoring of cardiovascular disease and diabetes.

Consumable of the PoC lipid test include test strips, cassette, and others. Point of care (PoC) has the potential to provide rapid blood and other critical care test results in close proximity to the patient. The test strip provides rapid test results and has the potential to improve patient care. Hospitals and specialty centres require regular supply of these consumables to ensure seamless operations and cater to the patients in a timely and efficient manner, which is majorly fuelling the segment’s growth in the global point of care (PoC) lipid test market.

Rising cases of chronic diseases such as liver and renal diseases, as well as diabetes, are expected to contribute to the growth of global point of care (PoC) lipid test market over the forecast period. The leading cause of death among pateitns with chronic kidney disease is cardiovascular disease (CVD). One of the most significant pathophysiological mechanisms for CVD in CKD patients is the widespread and possibly increased formation of atherosclerotic plaques owing to hyperlipidemia, uremic toxins, inflammation, and endothelial dysfunction. According to the United States. Department of Health and Human Services, chronic kidney disease (CKD) affects more than one in every seven adults in the United States or about 37 million people. The risk of CKD is even higher for people who have diabetes or high blood pressure, the two most common causes of kidney disease. Kidney disease affects nearly one-third of people with diabetes and one-fifth of people with high blood pressure.

Speak to our analyst in case of queries before buying this report:

The World Health Organization (WHO) declared a pandemic of a novel coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in March 2020. When COVID-19 cases began to rise worldwide, experts identified that the virus was especially dangerous for people with heart disease and related conditions, particularly for patients with high blood pressure. Telecommunication and internet technologies have been adopted to ensure seamless transformation of information in the required time. Patient portals were among one of the methods of connecting physicians with patients, who may be quarantined or working from home. The results of home testing devices can be downloaded into the patient’s medical record on these portals for review by the physician. Point of care (PoC) testing devices are becoming a more popular method of providing laboratory testing close to the patient with a quick turnaround of test results. Healthcare delivery is evolving to better meet the needs of patients. Initiatives by companies to adapt more seamlessly to changing market conditions showcases positive growth prospects for the global point of care (PoC) lipid test market over the forecast period.

According to the global figures, in 2021, North America accounted for the highest share in the global point of care (PoC) lipid test market. Countries such as the United States, Canada, and Mexico have made significant technology investments and are implementing advanced medical devices in the healthcare industry. Furthermore, the region’s high number of patients with cardiovascular diseases, combined with the presence of advanced medical infrastructure, contributes to the market growth. In order to produce high-quality products, manufacturers in this region are focusing on product development as well as the incorporation of advanced technologies, which is will fuel the market growth over the period of next eight years.

View our exclusive press releases on Industry Global News24

The key market participants operating in the global point of care (PoC) lipid test market are:

• Abaxis

• PTS Diagnostics

• A Menarini Diagnostics s.r.l

• Abbott

• EuroMedix

• F. Hoffmann-La Roche Ltd

• iXensor

• Nova Biomedical

• SD Biosensor, INC

• Siemens Healthcare GmbH

• Other Market Participants

Purchase the latest in-depth XYZGlobal Point of Care (POC) Lipid Test Market Report @

Global Point of Care (POC) Lipid Test Market:

By Offering

• Instruments

• Consumables

o Test Strips

o Cassette

o Others

By Disease Indication

• Lipid and Lipoprotein Disorders

o Hyperlipidemia

o Hypertriglyceridemia

o Familial Hypercholesterolemia

o Hyperlipoproteinemia

o Others

• Atherosclerosis

• Liver and Renal Diseases

• Diabetes Mellitus

• Others

By End Users

• Hospitals

• Physician Offices and Clinics

• Others

By Region

• North America

• Europe

• Asia Pacific

• Middle East & Africa

• Latin America

About Us:

Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

Contact Us:

Contact Name: Shreyas Tanna

Company: Absolute Markets Insights

Email Id:

Phone: IN +91-7400-24-24-24, US +1-510-420-1213


Shreyas Tanna
Absolute Markets Insights
+1 510-420-1213
Visit us on social media:

Disasters Expo USA, is proud to be supported by Inergency for their next upcoming edition on March 6th & 7th 2024!

The leading event mitigating the world’s most costly disasters is returning to the Miami Beach

Convention Center and we want you to join us at the industry’s central platform for emergency management professionals.
Disasters Expo USA is proud to provide a central platform for the industry to connect and
engage with the industry’s leading professionals to better prepare, protect, prevent, respond
and recover from the disasters of today.
Hosting a dedicated platform for the convergence of disaster risk reduction, the keynote line up for Disasters Expo USA 2024 will provide an insight into successful case studies and
programs to accurately prepare for disasters. Featuring sessions from the likes of The Federal Emergency Management Agency,
NASA, The National Aeronautics and Space Administration, NOAA, The National Oceanic and Atmospheric Administration, TSA and several more this event is certainly providing you with the knowledge
required to prepare, respond and recover to disasters.
With over 50 hours worth of unmissable content, exciting new features such as their Disaster
Resilience Roundtable, Emergency Response Live, an Immersive Hurricane Simulation and
much more over just two days, you are guaranteed to gain an all-encompassing insight into
the industry to tackle the challenges of disasters.
By uniting global disaster risk management experts, well experienced emergency
responders and the leading innovators from the world, the event is the hub of the solutions
that provide attendees with tools that they can use to protect the communities and mitigate
the damage from disasters.
Tickets for the event are $119, but we have been given the promo code: HUGI100 that will
enable you to attend the event for FREE!

So don’t miss out and register today:

And in case you missed it, here is our ultimate road trip playlist is the perfect mix of podcasts, and hidden gems that will keep you energized for the entire journey


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More